CliffBio
small molecule

EPANED

ENALAPRIL MALEATE

Loss of exclusivityMarch 2036latest FDA-listed patent expiry
CompanyAzurity Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameEPANED
Active ingredientENALAPRIL MALEATE
Strength1MG/ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2016
Marketing statusRX

Listed patents

PatentExpiresType
9808442March 2036use U-3
10154987March 2036use U-1723
11040023March 2036product
9669008March 2036product
10772868March 2036product
10786482March 2036product
10039745March 2036product
11173141March 2036product
11141405March 2036product

More from Azurity Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

EPANED patent cliff — loss of exclusivity March 2036 | CliffBio